NTRA

Natera
D

NTRA

Arincen62/100B

Natera stock forecast 2026–2028

Analysts' average 12-month price target for Natera is 393.16, 26.7% above the current price of 310.29. Their targets range from 245.00 to 500.00.

Of the 16 firms that rated Natera in the past 12 months, 14 rate it buy or strong buy, 2 hold and 0 sell or strong sell (each firm at its latest rating): a Strong buy consensus.

12-month price target
393.16 USD
+26.71%

Analysts' 1-year price targets range from 245.00 to 500.00, with an average of 393.16.

Past year
1-year forecast
Strong sellStrong buy
Strong buy
16 ratings
Strong buy
0
Buy
14
Hold
2
Sell
0
Strong sell
0

12-month price target

Highest target500.00
Average target393.16
Lowest target245.00
Current price310.29

Natera price target history

Have analysts recently raised or lowered their Natera price target and rating?

See how analysts moved their price target

How analysts rate Natera, month by month

14 of 16 firms rate it buy now, against 14 of 15 in December 2025.

Buy Hold Sell

Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.

Month endBuyHoldSellFirms
Nov 2026142016
Oct 2026142016
Sept 2026142016
Aug 2026142016
Jul 2026122014
Jun 2026122014
May 2026121013
Apr 2026121013
Mar 2026121013
Feb 2026121013
Jan 2026121013
Dec 2025141015

Natera analyst upgrades, downgrades and price targets

The latest rating change came on 5 June 2026, when Goldman Sachs downgraded Natera from Buy to Neutral. Its price target is 245.00. The most recent new target came from Piper Sandler on 6 November 2026: 363.50.

DateFirmRatingPrice targetChangePrice then
6 Nov 2026
Piper Sandler
Dave Westenberg
—249.00 → 363.50+46.0%310.68
27 Oct 2026
BTIG
Mark Massaro
Reiterated · Buy320.00 → 430.00+34.4%404.90

Natera EPS and revenue estimates

Revenue

ReportedEstimate

EPS

ReportedEstimate
Fiscal yearEPSEPS growthEPS rangeRevenueRevenue growthRevenue rangeAnalysts
FY2028 (est.) 1.27—-0.22 – 4.75 4.26B+21.1%3.96B – 4.82B14
FY2027 (est.) -0.37—-0.81 – -0.04 3.52B+20.9%3.45B – 3.58B13
FY2026 (est.) -1.45—-1.87 – -0.75 2.91B+26.2%2.83B – 2.93B13
FY2025 -1.53—— 2.31B+35.9%——
FY2024 -1.53—— 1.70B+56.7%——
FY2023 -3.79—— 1.08B+32.0%——
FY2022 -5.57—— 820.22M———

Does Natera beat earnings estimates?

On average, analysts' EPS estimate was 40.5% off the result, either way, and their revenue estimate 13.6%, over the last 12 quarters.

EPS beats
24 / 46
Revenue beats
31 / 46
Average EPS surprise, last 12
+16.1%
Since
August 2015
QuarterReport dateEPS estimateReported EPSSurpriseRevenue estimateReported revenueSurprise
Q3 FY20265 Nov 2026-0.28-0.42-49.3%707.54M793.98M+12.2%
Q2 FY20266 Aug 2026-0.49-0.47+4.8%661.24M752.75M+13.8%
Q1 FY20267 May 2026-0.54-0.56-3.3%617.10M696.64M+12.9%
Q4 FY202526 Feb 2026-0.510.35+168.4%604.04M665.50M+10.2%
Q3 FY20256 Nov 2025-0.39-0.64-65.9%513.45M592.18M+15.3%
Q2 FY20257 Aug 2025-0.62-0.74-20.2%476.26M546.60M+14.8%
Q1 FY20258 May 2025-0.64-0.50+21.9%446.23M501.83M+12.5%
Q4 FY202427 Feb 2025-0.38-0.41-7.6%435.64M476.06M+9.3%
Q3 FY202412 Nov 2024-0.57-0.26+54.4%361.43M439.76M+21.7%
Q2 FY20248 Aug 2024-0.69-0.30+56.5%343.00M413.35M+20.5%
Q1 FY20249 May 2024-0.71-0.56+21.1%316.31M367.74M+16.3%
Q4 FY202328 Feb 2024-0.73-0.64+12.3%300.00M311.11M+3.7%

Most undervalued US stocks

StockPriceFair valueUpside
99.090
195.09146Price 99.09244
+96.9%
186.680
359.93270Price 186.68450
+92.8%
213.670
405.66304Price 213.67507
+89.9%
161.160
305.51157Price 161.16396
+89.6%
42.225
79.0244Price 42.23157
+87.1%
160.650
299.85225Price 160.65375
+86.6%
108.445
201.41108Price 108.45248
+85.7%

Furthest below the fair value on each stock's page, updated every day.

Common questions about the Natera stock forecast

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.